Rubbish Check
NPR Business · September 28, 2026
source“Oura puts a ring on Wall Street with one of this year’s biggest IPOs”
R2/ 10
Lightly altered
Rubbish Rating — 1 = base fact, 10 = pure rubbish
12345678910
In short
Rubbish Talk rates NPR's claim that Oura's IPO is "one of this year's biggest" a 2/10 because the outlet's own reporting states the raise at "more than $2 billion" and balances the hype with lawsuit and privacy caveats in the same piece.
The Verdict
Lightly altered. The headline's "one of this year's biggest IPOs" is the same figure NPR itself reports in the body, and unlike a typical spin job, the piece doesn't hide the downside: it surfaces a class-action lawsuit over sleep-tracking accuracy and a doctor's warning about data-as-health-proxy in the same 661 words. The only iteration away from pure base fact is the punny, upbeat framing ("puts a ring on," "bet… will be a hit") that leans promotional in tone even as the substance stays balanced.
What actually happened
Oura plans to become a publicly traded company, making rings that track users' health data, and the company is expected to be one of this year's biggest IPOs, raising more than $2 billion. The company, founded in Finland 13 years ago, has run circles around its smartwatch rivals as smart rings gain ground with consumers wanting lighter, screen-free trackers.
Key facts
- IPO size: expected to be one of this year's biggest IPOs, raising more than $2 billion.
- User growth: Oura says its users have doubled for two years straight, and the median for how much people wear its tracking ring is 23 hours a day.
- Pricing/model: buying an Oura ring costs at least $350, with a subscription fee of $6 a month to access full health data, which helps make Oura reliably profitable.
- Data scale claim: in its first financial disclosure earlier this month, the company said it had "amassed one of the largest biometric datasets in consumer health" with nearly 42 billion hours of physiological data on its users.
- Risk disclosed in the same piece: this has critics raising concerns about data security and privacy, and a class-action lawsuit has questioned the quality of Oura's sleep tracking, which the company disputes.
What to watch for
Watch the actual pricing and first-day trade versus the "$2 billion-plus" raise figure quoted pre-IPO, that number can move once shares price. Also watch whether the class-action over sleep-tracking accuracy resurfaces in post-IPO coverage or investor disclosures, since it's the one hard risk factor buried past the headline.
About this scoreThe R-Score is Rubbish Talk's editorial opinion on how far a headline's framing sits from what the underlying facts support. It is a judgement about presentation and emphasis, not an allegation that any outlet has acted dishonestly. Every figure we rely on is linked under Receipts so you can check it yourself.
